ASLN - ASLAN Pharmaceuticals Ltd - ADR
Close
0.6
-0.100 -16.650%
Share volume: 806,352
Last Updated: Thu 18 Jul 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.10
-14.27%
View ratios
Fiscal Date | |
---|---|
Fiscal Quarter | |
Report Date | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating expenses | |
Selling general and admin | |
Research and development | |
Total expenses | |
Operating income | |
Ebit | |
Pretax income | |
Income tax | |
Net income basic | |
Net income |